Dietary antioxidants, fruits, and vegetables and the risk of barrett's esophagus

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1614-1623

  Kubo, Ai ^a   Levin, Theodore R ^a   Block, Gladys ^b   Rumore, Gregory J ^a   Quesenberry Jr , Charles P ^a   Buffler, Patricia ^b   Corley, Douglas A ^a,c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; SELENIUM;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; FEMALE; FOOD INTAKE; FRUIT; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT UPTAKE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; VEGETABLE; ADOLESCENT; CASE CONTROL STUDY; COMPARATIVE STUDY; DIET; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; BARRETT ESOPHAGUS; BETA CAROTENE; CASE-CONTROL STUDIES; DIET; FEMALE; FRUIT; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; VEGETABLES; VITAMIN E;

EID: 50649085028     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01838.x     Document Type: Article

References (49)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
2. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: An update. JAMA 1993;270:1320.
3. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
4. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26:2-8.
5. Kubo A, Corley DA. Marked regional variation in adeno- carcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002;95:2096-102.
6. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004;99:582-8.
7. Reid BJ, Barrett MT, Galipeau PC, et al. Barrett's esophagus: Ordering the events that lead to cancer. Eur J Cancer Prev 1996;5(Suppl 2):57-65.
8. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gas- troenterology 1995;109:1541-6.
9. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
10. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004;127:310-30.
11. Clarkson PM, Thompson HS. Antioxidants: What role do they play in physical activity and health? Am J Clin Nutr 2000;72:637S-46S.
12. Kubo A, Corley DA. Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol 2007;102:2323-30.
13. Moe GL, Kristal AR, Levine DS, et al. Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus. Nutr Cancer 2000;36:7-13.
14. Rudolph RE, Vaughan TL, Kristal AR, et al. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst 2003;95:750-7.
15. Chen X, Mikhail SS, Ding YW, et al. Effects of vitamin E and selenium supplementation on esophageal adenocar- cinogenesis in a surgical model with rats. Carcinogenesis 2000;21:1531-6.
16. Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma ofthe esophagus: Role ofobesityanddiet. JNatlCancerInst 1995;87:104-9.
17. Terry P, Lagergren J, Hansen H, et al. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev 2001;10:365-9.
18. Tzonou A, Lipworth L, Garidou A, et al. Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 1996;68:300-4.
19. Chen H, Ward MH, Graubard BI, et al. Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 2002;75:137-44.
20. Zhang ZF, Kurtz RC, Yu GP, et al. Adenocarcinomas ofthe esophagus and gastric cardia: The role of diet. Nutr Cancer 1997;27:298-309.
21. Mayne ST, Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 2002;132:3467S-70S.
22. Luo Y, Henle ES, Linn S. Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxycyti- dine family. J Biol Chem 1996;271:21167-76.
23. Hann HW, Stahlhut MW, Hann CL. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 1990;11: 566-9.
24. Barrett MT, Sanchez CA, Prevo LJ, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999;22:106-9.
25. Chen X, Yang G, Ding WY, et al. An esophagogastroduode- nal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 1999;20:1801-8.
26. Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study. World J Gastroenterol 2007;13:1585-94.
27. Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006;19:321-8.
28. Clements DM, Oleesky DA, Smith SC, et al. A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus. J Clin Pathol 2005;58:490-2.
29. Pollard J, Wild CP, White KL, et al. Comparison of plasma biomarkers with dietary assessment methods for fruit and vegetable intake. Eur J ClinNutr 2003;57:988-98.
30. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007;133:34-41.
31. Hiatt RA, Friedman GD. The frequency of kidney and urinary tract diseases in a defined population. Kidney Int 1982;22:63-8.
32. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 1992;82: 703-10.
33. Ofman JJ, Ryu S, Borenstein J, et al. Identifying patients with gastroesophageal reflux disease in a managed care organization. Am J Health Syst Pharm 2001;58:1607-13.
34. Block G, Hartman AM. Issues in reproducibility and validity of dietary studies. Am J Clin Nutr 1989;50:1133-8; discussion 1231 -5.
35. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
36. Block G, Thompson FE, Hartman AM, et al. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992;92:686-93.
37. Block G, Woods M, Potosky A, et al. Validation of a self- administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990;43:1327-35.
38. Sobell J, Block G, Koslowe P, et al. Validation of a retrospective questionnaire assessing diet 10-15 years ago. Am J Epidemiol 1989;130:173-87.
39. Coates RJ, Eley JW, Block G, et al. An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. Am J Epidemiol 1991;134:658-71.
40. Willett W, Stampfer M, Chu NF, et al. Assessment of questionnaire validity for measuring total fat intake using plasma lipid levels as criteria. Am J Epidemiol 2001;154:1107-12.
41. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia, PA: Lippincott-Raven, 1998.
42. Zhao Y, Ash A, Ellis R, et al. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care 2005;43:34-43.
43. Zhao Y, Ellis RP, Ash AS, et al. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Serv Res 2001;36:180-93.
44. Terry P, Lagergren J, Ye W, et al. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000;87:750-4.
45. Bollschweiler E, Wolfgarten E, Nowroth T, et al. Vitamin intake andrisk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol 2002;128:575-80.
46. Gonzalez CA, Pera G, Agudo A, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006;118:2559-66.
47. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC: AICR, 2007.
48. Morrison AS. Screening in chronic disease. New York: Oxford University Press, 1992.
49. Kristal AR, Blount PL, Schenk JM, et al. Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev 2005;14:2377-83.